Adapted ear canal device for drug delivery
DE602016091881T2Active Publication Date: 2025-04-09EARLENS CORP
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- DE602016091881
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2016-09-16
- Filing Date
- 2016-09-30
- Publication Date
- 2025-04-09
- Estimated Expiration
- 2036-09-30
AI Technical Summary
Technical Problem
Existing hearing systems and drug delivery devices lack the capability to simultaneously collect biometric data and deliver drugs in a non-invasive, long-term, and user-compliant manner.
Method used
A wearable system is positioned in the ear canal, equipped with sensors to detect biometric data and a drug delivery mechanism that can be placed on the tympanic membrane for extended periods, allowing for sustained, timed, or algorithm-controlled drug delivery.
Benefits of technology
The system effectively collects biometric data and delivers drugs to highly vascular areas of the ear canal, ensuring user compliance and reducing side effects by local drug delivery, all while being non-invasive and long-lasting.
✦ Generated by Eureka AI based on patent content.
Need to check novelty before this filing date? Find Prior Art
No text content released.